ARTICLE | Clinical News
Enzo regulatory update
January 3, 1994 8:00 AM UTC
ENZ (Farmingdale, NY) received U.S. Patent No. 5,272,065, covering the regulation of gene activity using genetic antisense technology. The patent covers the use of nucleic acid constructs and the use ...